PROPOSED AMENDMENTS TO HOUSE BILL 3440

Similar documents
79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3440

SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION

SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2217

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014

ASSEMBLY, No. 542 STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

A Bill Regular Session, 2015 SENATE BILL 880

[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016

Be it enacted by the People of the State of Illinois,

3 By Representatives Sells, Weaver, Harper, South, McCutcheon, 4 Harbison, Butler, Mooney, Hanes, Williams (JW), Wilcox, Scott,

Sub. S.B. 119 As Passed by the Senate

Naloxone Access Statutes

2016 Dr. Douglas H. Kay CPE Symposium

Public Health Impacts of 2016 West Virginia Legislation

Naloxone Access Statutes

Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

Dispensing and administration of emergency opioid antagonist without a

Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions

Model Intervention for Students with Substance Abuse Problems Act

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]

SUMMARY Provides for the award of certain grants relating to the prevention and treatment

CHAPTER House Bill No. 1429

RESIDENTIAL SERVICE PROTECTION FUND

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

SELF-ADMINISTERED MEDICATION AND EPINEPHRINE USE

A Bill Regular Session, 2005 HOUSE BILL 1231

The Changing Landscape of Opioids & Workers Compensation. Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency

A Bill Regular Session, 2015 SENATE BILL 717

Good Samaritan and Naloxone Bill Status Report Carryover 2016 and Special Sessions

PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC )

[CORRECTED COPY] CHAPTER 115

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

STATE OF HAWAI I DEPARTMENT OF EDUCATION P.O. BOX 2360 HONOLULU, HAWAI I LEGISLATIVE REPORT

S 0332 S T A T E O F R H O D E I S L A N D

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

House Bill 2198 Ordered by the House July 1 Including House Amendments dated June 2 and July 1

No An act relating to health insurance coverage for early childhood developmental disorders, including autism spectrum disorders. (S.

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 2198

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW HOUSE BILL 243

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. Senate Bill 1544

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

Temple University Beasley School of Law. Project on Harm Reduction in the Health Care System

Senate Bill No. 481 Committee on Health and Human Services

H 7816 S T A T E O F R H O D E I S L A N D

NC General Statutes - Chapter 90 Article 5E 1

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

10/20/14& the administration of nasal naloxone by school nurses. for nasal naloxone

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Michigan Opioid Legislation Hospital Compliance Checklist

Drug Overdose Prevention Program (DOPP)

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

Senate Bill No. 174 Senator Carlton CHAPTER...

FL AT Act As amended 5/30/06 by Chapter (SB 366) (Amendments not noted; see SB 366 file for changes) PART XIII ATHLETIC TRAINERS

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

For An Act To Be Entitled. Subtitle

South Carolina General Assembly 122nd Session,

MARYLAND BOARD OF PHARMACY

S 2356 SUBSTITUTE A AS AMENDED ======== LC004564/SUB A/3 ======== S T A T E O F R H O D E I S L A N D

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3460

As Passed by the House. Regular Session Sub. H. B. No

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers

78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY

H 8313 S T A T E O F R H O D E I S L A N D

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

OPIOID EMERGENCY RESPONSE REGULATION

As Passed by the House. Regular Session H. B. No

SENATE BILL No. 501 AMENDED IN SENATE MAY 1, 2017 AMENDED IN SENATE APRIL 20, 2017 AMENDED IN SENATE APRIL 17, Introduced by Senator Glazer

CRITICAL POLICY REFERENCE MANUAL FILE CODE: X Monitored X Mandated Sample Policy X Other Reasons

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

R ADMINISTERING AN OPIOID ANTIDOTE. B. Acquisition, Maintenance, Accessibility, and Documentation of an Opioid Antidote

First Regular Session Seventy-first General Assembly STATE OF COLORADO INTRODUCED SENATE SPONSORSHIP HOUSE SPONSORSHIP

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

are being added to products that have the same or similar effects exercised emergency scheduling authority to control five (5)

A Bill Regular Session, 2017 HOUSE BILL 1250

Legal Considerations for. Immunizations

CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION

Home Model Legislation Public Safety and Elections. Methamphetamine Reduction Act

Senate File Introduced

Secretary of the Senate. Chief Clerk of the Assembly. Private Secretary of the Governor

Prescription Monitoring Program (PMP)

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 2760

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HJR

IC ARTICLE 48. CONTROLLED SUBSTANCES

The Opioid Crisis: Effectiveness of State Responses

76th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. Senate Bill 738 CHAPTER... AN ACT

Prescription Opioid Overdose in Oregon: A public health perspective

SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION

LAWS OF ALASKA AN ACT

Maryland s Good Samaritan Law

Transcription:

HB 0- (LC ) // (MBM/ps) Requested by Representative WILLIAMSON PROPOSED AMENDMENTS TO HOUSE BILL 0 1 On page 1 of the printed bill, line, delete 1A. and. Delete lines through and pages through and insert: NALOXONE 1 1 SECTION 1. ORS.1, as amended by section, chapter 0, Oregon Laws, is amended to read:.1. (1) As used in this section: (a) Opiate means a narcotic drug that contains: (A) Opium; (B) Any chemical derivative of opium; or (C) Any synthetic or semisynthetic drug with opium-like effects. (b) Opiate overdose means a medical condition that causes depressed consciousness and mental functioning, decreased movement, depressed respiratory function and the impairment of the vital functions as a result of ingesting opiates in an amount larger than can be physically tolerated. [() The Oregon Health Authority shall establish by rule protocols and criteria for training on lifesaving treatments for opiate overdose. The criteria must specify:] [(a) The frequency of required retraining or refresher training; and] [(b) The curriculum for the training, including:]

1 1 0 [(A) The recognition of symptoms and signs of opiate overdose;] [(B) Nonpharmaceutical treatments for opiate overdose, including rescue breathing and proper positioning of the victim;] [(C) Obtaining emergency medical services;] [(D) The proper administration of naloxone to reverse opiate overdose; and] [(E) The observation and follow-up that is necessary to avoid the recurrence of overdose symptoms.] [() Training that meets the protocols and criteria established by the authority under subsection () of this section must be subject to oversight by a licensed physician or certified nurse practitioner and may be conducted by public health authorities, organizations or other appropriate entities that provide services to individuals who take opiates.] [()] () Notwithstanding any other provision of law, a pharmacy, a health care professional or a pharmacist with prescription and dispensing privileges or any other person designated by the State Board of Pharmacy by rule may distribute [unit-of-use packages of naloxone,] and administer naloxone and distribute the necessary medical supplies to administer the naloxone[, to a person who:]. [(a) Conducts training that meets the protocols and criteria established by the authority under subsection () of this section, so that the person may possess and distribute naloxone and necessary medical supplies to persons who successfully complete the training; or] [(b) Has successfully completed training that meets the protocols and criteria established by the authority under subsection () of this section, so that the person may possess and administer naloxone to any individual who appears to be experiencing an opiate overdose.] [() A person who has successfully completed the training described in this section is immune from civil liability for any act or omission committed during the course of providing the treatment pursuant to the authority granted by this HB 0- // Proposed Amendments to HB 0 Page

1 1 0 section, if the person is acting in good faith and the act or omission does not constitute wanton misconduct.] () A person acting in good faith, if the act does not constitute wanton misconduct, is immune from civil liability for any act or omission of an act committed during the course of distributing and administering naloxone and distributing the necessary medical supplies to administer the naloxone under this section. SECTION. Section, chapter 0, Oregon Laws, is amended to read: Sec.. In accordance with rules adopted by the State Board of Pharmacy under ORS., a pharmacist may prescribe [unit-of-use packages of] naloxone[,] and the necessary medical supplies to administer the naloxone[, to a person who meets the requirements of ORS.1 ()]. SECTION. Section, chapter 0, Oregon Laws, is amended to read: Sec.. (1) For purposes of this section, social services agency includes, but is not limited to, homeless shelters and crisis centers. () An employee of a social services agency may administer to an individual [a unit-of-use package of] naloxone that was not distributed to the employee [if:] if the individual appears to be experiencing an opiate overdose as defined in ORS.1. [(a) The employee conducts or has successfully completed opiate overdose training under ORS.1;] [(b) The unit-of-use package of naloxone was distributed to another employee of the social services agency who conducts or has completed the opiate overdose training under ORS.1; and] [(c) The individual appears to be experiencing an opiate overdose as defined in ORS.1.] () For the purposes of protecting public health and safety, the Oregon Health Authority may adopt rules for the administration of naloxone under HB 0- // Proposed Amendments to HB 0 Page

this section. PRIOR AUTHORIZATION SECTION. (1) In reimbursing the cost of medication prescribed for the purpose of treating opioid or opiate withdrawal, an insurer offering a health benefit plan as defined in ORS B.00 may not require prior authorization of payment for the initial 0-day supply of the medication. () This section is not subject to ORS A.001. SECTION. Section of this Act applies to reimbursements made pursuant to health benefit plans entered into or renewed on or after the effective date of this Act. SPECIALTY COURTS 1 1 SECTION. (1) As used in this section, specialty court has the meaning given that term in ORS.0. () An individual may not be denied entry into a specialty court in this state solely for the reason that the individual is taking, or intends to take, medication prescribed by a licensed health care practitioner for the treatment of drug abuse or dependency. TREATMENT INFORMATION 0 SECTION. (1) The Oregon Health Authority shall develop and regularly update a web-based, searchable inventory of the following: (a) Each opioid and opiate abuse or dependency treatment provider located in this state; (b) Treatment options offered by each opioid and opiate abuse or HB 0- // Proposed Amendments to HB 0 Page

dependency treatment provider located in this state; and (c) The maximum capacity of each opioid and opiate abuse or dependency treatment provider located in this state. () The authority shall post the inventory developed under subsection (1) of this section on a website of the authority. SECTION. (1) In developing the inventory required by section of this Act, the Oregon Health Authority shall analyze the data to determine whether identifiable geographic regions have insufficient treatment options for, or capacity to treat individuals suffering from, opioid or opiate abuse or dependency. () Not later than September of each year, the authority shall report to the interim committees of the Legislative Assembly related to health care, in the manner provided by ORS 1., on identifiable geographic regions that have insufficient treatment options for, or capacity to treat individuals suffering from, opioid or opiate abuse or dependency. 1 ANNUAL REPORTING 1 0 SECTION. (1) From resources available to the Oregon Health Authority, the authority shall compile statistics on the total number of opioid and opiate overdoses and the total number of opioid and opiate overdose related deaths occurring in this state. () Not less than once every three months, the authority shall report to the Governor and each local health department, as defined in ORS 1.00, the statistics compiled under subsection (1) of this section. () Not later than September of each year, the authority shall report to the interim committees of the Legislative Assembly related to health care, in the manner provided by ORS 1., the statistics HB 0- // Proposed Amendments to HB 0 Page

compiled under subsection (1) of this section. MISCELLANEOUS 1 1 SECTION. (1) Sections, and of this Act become operative on January 1, 1. () The Oregon Health Authority may take any action before the operative date specified in subsection (1) of this section that is necessary to enable the authority to exercise, on and after the operative date specified in subsection (1) of this section, all the duties, functions and powers conferred on the authority by sections, and of this Act. SECTION. Section of this Act is added to and made a part of the Insurance Code. SECTION. The unit captions used in this Act are provided only for the convenience of the reader and do not become part of the statutory law of this state or express any legislative intent in the enactment of this Act. SECTION. This Act takes effect on the 1st day after the date on which the regular session of the Seventy-ninth Legislative Assembly adjourns sine die.. HB 0- // Proposed Amendments to HB 0 Page